Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128544) titled 'Association between Serum Magnesium Disorders and Patient Prognosis' on July 22.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Xuanwu Hospital Capital Medical University
Condition:
Hypomagnesemia
Hypermagnesemia
Intervention:
Hypermagnesemia group:None
Hypomagnesemia group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-31
Target Sample Size: Hypermagnesemia group:500;Hypomagnesemia group:1000;Normal magnesium group:3500;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=329497
Pu...